Key result
In a community survey of type II diabetic patients, >40% had hyperlipidemia, yet only ~25% of non-Hispanic whites and fewer Mexican-Americans were aware of it, with <10% receiving treatment.
Why the study?
What is the prevalence, awareness, and treatment rate of hyperlipidemia among Mexican-American and non-Hispanic white patients with type II diabetes in a community setting?
Population
460 subjects with type II diabetes identified from a community epidemiologic survey of 5,126 individuals in…
Design
Cross-sectional
Authors
Loading...
Signals urgent gaps in hyperlipidemia management among diabetics; leaves open targeted strategies to address ethnic disparities.
Cross-Sectional (n=5,126)
No
What is the prevalence, awareness, and treatment rate of hyperlipidemia among Mexican-American and non-Hispanic white patients with type II diabetes in a community setting?
Despite a high prevalence of hyperlipidemia among patients with type II diabetes, awareness and treatment rates are severely inadequate, highlighting a major gap in cardiovascular disease prevention.
Michael P. Stern (1989) conducted a cross-sectional in Type II diabetes mellitus and hyperlipidemia (n=5,126). In a community survey of type II diabetic patients, >40% had hyperlipidemia, yet only ~25% of non-Hispanic whites and fewer Mexican-Americans were aware of it, with <10% receiving treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: